Related Experiment Video
Updated: Apr 23, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Emerging issues in pediatric asthma: gaps in EPR-3 guidelines for infants and children
1Division of Allergy, Immunology and Rheumatology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue K4/936 CSC, Madison, WI, 53792-9988, USA, djj@medicine.wisc.edu.
Insights
This review discusses updated asthma treatment strategies for children, including new long-term, intermittent, and emerging therapies. It addresses gaps in current care guidelines and suggests future research directions for recurrent wheezing in pediatric patients.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Therapeutics
Background:
- Recurrent wheezing and asthma in children present complex treatment challenges.
- The National Heart, Lung, and Blood Institute's (NHLBI) Expert Panel Report-3 (EPR-3) from 2007 offers foundational guidance.
- Subsequent clinical trials have expanded the evidence base for pediatric asthma management.
Purpose of the Study:
- To review contemporary approaches to pediatric asthma therapy.
- To discuss advancements beyond the EPR-3 guidelines.
- To identify areas needing further research in childhood asthma.
Main Methods:
- Literature review of recent clinical trials and therapeutic strategies.
- Analysis of new approaches in long-term, intermittent, and emerging asthma treatments.
- Discussion of guideline-based care gaps.
Main Results:
- New therapeutic strategies for long-term asthma control are presented.
- Intermittent fixed-dose and dynamic dosing therapies are examined.
- Emerging treatments and their potential impact are discussed.
Conclusions:
- Updated evidence informs current pediatric asthma care.
- Further research is needed to address remaining gaps in guideline-based management.
- Optimizing treatment for recurrent wheezing in children requires ongoing evaluation.
Abstract:
There are many complexities to the treatment of infants and children with recurrent wheezing and asthma. The National Heart, Lung and Blood Institute's (NHLBI's) Expert Panel Report-3 (EPR-3), published in 2007, provides guidance to clinicians who care for infants and children with asthma. Since that time, many important clinical trials have further informed the evidence base available to clinicians. In this manuscript, new approaches to long-term therapy, intermittent fixed-dose and dynamic dose therapies, and emerging therapies for asthma are reviewed. Further, additional gaps in guideline-based care and areas for future research are discussed.
Related Concept Videos
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
